Quest Diagnostics Common Stock Net 2010-2024 | DGX
Quest Diagnostics common stock net from 2010 to 2024. Common stock net can be defined as the value of common equity ownership.
- Quest Diagnostics common stock net for the quarter ending September 30, 2024 was $0.002B, a 0% increase year-over-year.
- Quest Diagnostics common stock net for 2023 was $0.002B, a 0% decline from 2022.
- Quest Diagnostics common stock net for 2022 was $0.002B, a 0% decline from 2021.
- Quest Diagnostics common stock net for 2021 was $0.002B, a 0% decline from 2020.
Quest Diagnostics Annual Common Stock Net
(Millions of US $) |
| 2023 |
$2 |
| 2022 |
$2 |
| 2021 |
$2 |
| 2020 |
$2 |
| 2019 |
$2 |
| 2018 |
$2 |
| 2017 |
$2 |
| 2016 |
$2 |
| 2015 |
$2 |
| 2014 |
$2 |
| 2013 |
$2 |
| 2012 |
$2 |
| 2011 |
$2 |
| 2010 |
$2 |
| 2009 |
$2 |
Quest Diagnostics Quarterly Common Stock Net
(Millions of US $) |
| 2024-09-30 |
$2 |
| 2024-06-30 |
$2 |
| 2024-03-31 |
$2 |
| 2023-12-31 |
$2 |
| 2023-09-30 |
$2 |
| 2023-06-30 |
$2 |
| 2023-03-31 |
$2 |
| 2022-12-31 |
$2 |
| 2022-09-30 |
$2 |
| 2022-06-30 |
$2 |
| 2022-03-31 |
$2 |
| 2021-12-31 |
$2 |
| 2021-09-30 |
$2 |
| 2021-06-30 |
$2 |
| 2021-03-31 |
$2 |
| 2020-12-31 |
$2 |
| 2020-09-30 |
$2 |
| 2020-06-30 |
$2 |
| 2020-03-31 |
$2 |
| 2019-12-31 |
$2 |
| 2019-09-30 |
$2 |
| 2019-06-30 |
$2 |
| 2019-03-31 |
$2 |
| 2018-12-31 |
$2 |
| 2018-09-30 |
$2 |
| 2018-06-30 |
$2 |
| 2018-03-31 |
$2 |
| 2017-12-31 |
$2 |
| 2017-09-30 |
$2 |
| 2017-06-30 |
$2 |
| 2017-03-31 |
$2 |
| 2016-12-31 |
$2 |
| 2016-09-30 |
$2 |
| 2016-06-30 |
$2 |
| 2016-03-31 |
$2 |
| 2015-12-31 |
$2 |
| 2015-09-30 |
$2 |
| 2015-06-30 |
$2 |
| 2015-03-31 |
$2 |
| 2014-12-31 |
$2 |
| 2014-09-30 |
$2 |
| 2014-06-30 |
$2 |
| 2014-03-31 |
$2 |
| 2013-12-31 |
$2 |
| 2013-09-30 |
$2 |
| 2013-06-30 |
$2 |
| 2013-03-31 |
$2 |
| 2012-12-31 |
$2 |
| 2012-09-30 |
$2 |
| 2012-06-30 |
$2 |
| 2012-03-31 |
$2 |
| 2011-12-31 |
$2 |
| 2011-09-30 |
$2 |
| 2011-06-30 |
$2 |
| 2011-03-31 |
$2 |
| 2010-12-31 |
$2 |
| 2010-09-30 |
$2 |
| 2010-06-30 |
$2 |
| 2010-03-31 |
$2 |
| 2009-12-31 |
$2 |
| 2009-09-30 |
$2 |
| 2009-06-30 |
$2 |
| 2009-03-31 |
$2 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$18.293B |
$9.252B |
|
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
|
